Bethany Sensenig

SUPN

Bethany Sensenig serves as director at Supernus Pharmaceuticals, Inc. (SUPN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$683.4K

Net Position

Net Seller

$683.4K

Companies Traded

SUPN

Active Period

Aug 2025 – Feb 2026

3 total trades

Most Recent

Sell SUPN

Feb 23, 2026 · $228.3K

Bethany Sensenig's Insider Trading at Supernus Pharmaceuticals, Inc. (SUPN)

Buys

0 · $0.00

Sells

3 · $683.4K

Total Shares Bought

Total Shares Sold

14,319

SUPN Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 23, 2026↗	Sell	4,475	$51.01	$228.3K	3,258
Feb 19, 2026↗	Sell	4,475	$51.01	$228.3K	0
Aug 14, 2025↗	Sell	5,369	$42.25	$226.8K	0

Related Insiders

William Todd Horich

officer: SVP, Commercial Operations

SUPNSell · Mar 10, 2026

Frank Mottola

officer: SVP, Chief Tech. Ops. Officer

SUPNSell · Mar 9, 2026

GEMAYEL GEORGES

director

SUPNSell · Mar 6, 2026

Frank Mottola

SVP, Chief Tech. Ops. Officer

SUPNSell · Dec 19, 2025

Padmanabh P. Bhatt

Sr. VP of IP, CSO

SUPNSell · Dec 18, 2025

Jack A. Khattar

President, CEO

SUPNSell · Oct 9, 2025

NEWHALL CHARLES W III

Director

SUPNSell · Oct 9, 2025

Jonathan Rubin

SVP, Chief Medical Officer

SUPNSell · Sep 25, 2025

Explore More Insider Trading Data

SUPN Insider Trading Activity

View all insider trades at Supernus Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity